Long-term treatment of destructive rheumatoid arthritis with methotrexate.

Abstract

Even in patients with longstanding, active, destructive RA who failed one or more DMARD, MTX treatment is well tolerated and improves clinical and biochemical disease activity significantly, while radiographic progression is still present.